Increased FGF-23 is an early alteration in CKD-MBD, and low 25(OH) vitamin D levels and high FGF-23 levels are independent predictors of poor renal outcomes, progression to renal replacement therapy, and all-cause mortality [24,36,37]. The gene discussed is FGF23; the disease is Marchiafava-Bignami disease.